The purpose of this study is to confirm the effect of ANT-1401 in the treatment of Lateral Canthal Lines.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
109
Unnamed facility
Birmingham, Alabama, United States
Unnamed facility
Miami, Florida, United States
Unnamed facility
Pinellas Park, Florida, United States
Unnamed facility
West Palm Beach, Florida, United States
Investigator's Global Assessment Scale
Time frame: Week 4
Subject Self-Assessment
Time frame: Week 4
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Unnamed facility
Louisville, Kentucky, United States
Unnamed facility
Metairie, Louisiana, United States
Unnamed facility
Knoxville, Tennessee, United States